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Sixteen female cross-bred (Large White £ Landrace) pigs (initial weight 65 kg) with venous
catheters were randomly allocated to four treatment groups in a 2 £ 2 factorial design. The
respective factors were dietary fat (25 or 100 g/kg) and dietary conjugated linoleic acid
(CLA; 0 or 10 g CLA-55/kg). Pigs were fed every 3 h (close to ad libitum digestible energy
intake) for 8 d and were bled frequently. Plasma glucose and non-esterified fatty acid
(NEFA) responses to insulin and adrenaline challenges were determined on day 8. Plasma con-
centrations of NEFA were significantly increased (10·5 and 5·4 % for low- and high-fat diets
respectively, P¼0·015) throughout the experiment, suggesting that there was a possible
increase in fat mobilisation. The increase in lipolysis, an indicator of ß-adrenergic stimulated
lipolysis, was also evident in the NEFA response to adrenaline. However, the increase in
plasma triacylglycerol (11·0 and 7·1 % for low- and high-fat diets respectively, P¼0·008) indi-
cated that CLA could have reduced fat accretion via decreased adipose tissue triacylglycerol
synthesis from preformed fatty acids, possibly through reduced lipoprotein lipase activity.
Plasma glucose, the primary substrate for de novo lipid synthesis, and plasma insulin levels
were unaffected by dietary CLA suggesting that de novo lipid synthesis was largely unaffected
(P¼0·24 and P¼0·30 respectively). In addition, the dietary CLA had no effect upon the ability
of insulin to stimulate glucose removal.
Conjugated linoleic acids: Lipid metabolism: Pigs
The potential of conjugated linoleic acids (CLA) to reduce
body fat deposition has been well documented (Albright
et al. 1996; Park et al. 1997; West et al. 1998; DeLany
et al. 1999; Ostrowska et al. 1999; Park et al. 1999a,b;
Satory & Smith, 1999), but whether the reduction in fat depo-
sition is due to increased lipolysis (fat breakdown) or
decreased lipogenesis (fat synthesis) is unclear. One way to
understand the in vivo metabolic responses to CLA better is
by studying the temporal pattern of intermediate metabolite
and hormone concentrations. The effect of CLA treatment
on lipolysis can be further investigated by determining the
metabolic responses to homeostatic signals, such as adrena-
line or insulin. Adrenaline stimulates ß-adrenergic lipolysis
(Sechen et al. 1990; Dunshea et al. 1995; Dunshea & King,
1995), whereas insulin enhances storage of fat while inhibit-
ing the mobilisation and oxidation of fatty acids in vivo
(Dunshea et al. 1995; Dunshea & King, 1995). Quantifying
the plasma glucose response to insulin may also help to
establish whether CLA induces insulin resistance, as this is
characterised by high levels of plasma glucose and insulin
(Dunshea & King, 1994). These techniques have previously
been used to determine the mode of action of metabolic
modifiers such as somatotropin (Sechen et al. 1990; Boisclair
et al. 1994) and ractopamine (Dunshea et al. 1995; Dunshea
& King, 1995).
The first objective of the present study was to determine
the effect of the CLA treatment on plasma variables related
to lipolysis and lipogenesis in growing pigs. The second
objective was to measure the metabolic responses to the
homeostatic signals, adrenaline and insulin.
Experimental methods
Animals and treatments
All procedures involving animals were approved by the
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Victorian Institute of Animal Science Animal Ethics Com-
mittee. Twenty female cross-bred (Large White £ Land-
race) gilts (initial weight 65 kg) were catheterised 7 d
before commencement of the study. Muscle relaxation
was induced with an intramuscular injection of xylazine
(20 mg xylazine.HCl/ml; Troy Labs Pty. Ltd, Smithfield,
New South Wales, Australia) and ketamine (100 mg keta-
mine.HCl/ml; Troy Labs Pty. Ltd) at 0·05 ml and 0·1 ml/
kg body weight respectively. The anaesthesia was main-
tained with halothane (Rhone Merieux, Footscray West,
Victoria, Australia) inhalation. A silastic catheter was
inserted 0·15 m into the anterior vena cava via the cephalic
vein. The catheter was exteriorised in the region of inter-
scapular space on the back of each animal and stored in
a cloth pocket glued to the back. After catheterisation,
pigs were given 10 mg broad-spectrum antibiotic Enge-
mycin 100 (100 mg oxytetracycline hydrochloride/ml;
Intervet (Australia) Pty. Ltd, Castle Hill, New South
Wales, Australia)/kg body weight. The twenty surgically
prepared gilts were monitored for feeding behaviour,
rectal temperature, general disposition and defecation
frequency. Any pigs with elevated temperatures (.398C)
were given 5 mg Penbritin (ampicilin sodium; Beecham
Veterinary Products, Dandenong, Victoria, Australia)/kg
body weight. Catheters were flushed daily with physio-
logical saline containing K2EDTA (12·5 g/l). The sixteen
gilts with the best functional catheters were blocked on
live weight and within blocks randomly allocated to four
treatment groups in a 2 £ 2 factorial design. The respective
factors were level of dietary CLA (0 and 10 g/kg) and total
dietary fat (25 and 100 g/kg).
Four days before the initiation of the dietary treatments,
all pigs were fed a diet containing no CLA and an inter-
mediate fat level (about 60 g/kg) (75 kJ digestible energy/
kg live weight) every 3 h (about 2·5 kg feed/d for a 60 kg
pig or approximately 90 % ad libitum digestible energy)
to ensure a relatively steady state for measuring plasma
metabolites. On day 1, pigs were offered their respective
experimental diets at the same rate and frequency for 8 d.
Pigs were fed either a low-fat diet (total fat 25 g/kg;
Table 1) or a high-fat diet (total fat 100 g/kg; Table 1)
with either 0 or 10 g CLA-55 (CLA containing 55 g fatty
acids as CLA isomers/100 g total fatty acids; Natural
Lipids Ltd, Hovdebygda, Norway)/kg. Pigs were fed for
8 d, during which time they were bled frequently (see
later). The added fat in the high-fat diet was provided as
palm oil, thereby ensuring that saturated fatty acids were
the predominant preformed fatty acids. The wheat-based
diets were formulated to contain 14 and 15 MJ digestible
energy/kg low- and high-fat diet respectively.
After commencing the dietary treatments, all pigs were
bled (8 ml blood) at intervals of 3 h (immediately before
each feeding) for 48 h. From day 3 until day 7 pigs were
bled twice per d immediately prior to feeding at 09.00
and 18.00 hours. Previous studies have demonstrated that
plasma metabolites are in a steady state in pigs fed at inter-
vals of 2 to 4 h (Dunshea et al. 1992a; Dunshea & King,
1994) and it was felt that two samples taken 9 h apart
would be representative of plasma metabolite concen-
trations in these pigs. A subsequent 24 h bleed took place
on day 7 (at intervals of 3 h for 24 h). Blood was collected
by first removing the contents of the cannula with a syringe
and discarding it. The syringe was then attached to the
cannula and blood was withdrawn to ensure unrestricted
blood flow. The cannulas were flushed and re-filled after
blood collections with anticoagulant (12·5 g K2EDTA/l
saline (0·15 M-NaCl)) and were secured in the pouch.
Challenges
On the morning of day 8, half the animals from each diet-
ary treatment were challenged with a dose (3mg/kg body
weight) of insulin (Astra Pharmaceuticals Pty. Ltd, North
Ryde, New South Wales, Australia) diluted in sterile
saline (0·15 M-NaCl). Adrenaline (1·82 mg adrenaline acid
tartrate/ml; Astra Pharmaceuticals Pty. Ltd) diluted in ster-
ile saline (0·15 M-HCl) was administered to the remaining
pigs via the catheter (3mg/kg body weight). The injections
were reversed in the afternoon. Both the adrenaline and
insulin were injected via the catheter, immediately fol-
lowed by 5 ml sterile saline. Blood (5 ml) was collected
frequently for 1 h before and 2 h after each injection. The
bleeding for each challenge took place at 260, 230,
215, 21, 3, 6, 10, 15, 20, 30, 45, 60, 90, 120 min relative
to the injections. Pre-bleeding for basal samples com-
menced 30 min before feed was dispensed for the feeds
at 09.00 and 15.00 hours. Plasma glucose and non-esteri-
fied fatty acid (NEFA) responses to insulin and adrenaline
were determined on day 8. The following day, the catheters
were removed. Whole blood was stored on ice immediately
after the bleeding and centrifuged at 2000 g to separate
the plasma. Plasma was portioned into three separate
Table 1. Composition of the low- and high-fat diets
Low-fat diet* High fat diet†
Ingredient (g/kg) Control CLA Control CLA
Wheat 189·4 189·4 484·8 484·8
Starch 236·0 236·0 0·0 0·0
Raw sugar 250·0 250·0 0·0 0·0
DL-Methionine 2·5 2·5 0·6 0·6
L-Lysine HCl 2·5 2·5 0·0 0·0
L-Threonine 2·3 2·3 0·8 0·8
Dicalcium phosphate 23·3 23·3 24·4 24·4
NaCl 2·0 2·0 2·0 2·0
Limestone 0·0 0·0 6·9 6·9
Vitamin and mineral premix‡ 2·0 2·0 2·0 2·0
Blood meal 30·0 30·0 0·0 0·0
Fish meal 50·0 50·0 50·0 50·0
Soyabean meal 200·0 200·0 149·0 149·0
Palm oil 10·0 0·0 80·0 70·0
CLA-55§ 0·0 10·0 0·0 10·0
CLA, conjugated linoleic acid.
* Diet was formulated to contain 14 MJ digestible energy, 183 g crude protein
ðN £ 6·25Þ and 10·3 g available lysine/kg air-dried diet.
† Diet was formulated to contain 15 MJ digestible energy, 206 g crude protein
ðN £ 6·25Þ and 11·3 g available lysine/kg air-dried diet.
‡ Provided the following nutrients (mg/kg air-dry diet; retinol 6·4, cholecalci-
ferol 0·083, a-tocopherol 22, menadione 0·60, riboflavin 3·3, nicotinic acid
16·5, pantothenic acid 5·5, pyridoxine 1·1, biotin, 0·56, choline 1100, cya-
nocobalamin 0·017, Fe 88, Zn 55, Mn 22, Cu 6·6, I 0·22, Se 0·1.
§ CLA nominally contained 55 g fatty acids as CLA isomers/100 g total fatty
acids.
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vials and stored at 2208C until analysed for metabolite
concentrations.
Chemical analysis
Plasma triacylglycerol concentrations were analysed using
an Infinitye Triacylglycerol Reagent kit (procedure no.
343; Sigma-Aldrich Pty. Ltd, Castle Hill, New South
Wales, Australia). Plasma glucose and urea N concen-
trations were analysed using a Sigma kit (procedure no.
510 and no. 640 respectively; Sigma-Aldrich Pty. Ltd).
Both assays were modified to accommodate the range of
concentrations of plasma glucose and plasma urea encoun-
tered in the pig. Plasma insulin was measured using a por-
cine insulin radioimmunoassay kit (catalogue no. PI-12 K;
Linco Research, Inc., St Charles, MO, USA). Plasma
NEFA levels were assayed using NEFA C ACS-ACOD
method (Wako Pure Chemicals Industries Ltd, Doshoma-
chi 3-Chome, Chuo-Ku, Osaka 541, Japan) modified for
microtitre plates (Johnson & Peters, 1993).
Statistical analysis
The experimental design included four treatment groups in
a 2 £ 2 factorial design. Average daily concentrations of
key metabolites and hormones in plasma during the treat-
ment period were compared using a repeated-measures
mixed model analysis (Genstat for Windows, version 4.1;
Payne et al. 1993). The respective factors were level of
dietary CLA (0 and 10 g/kg) and total fat in the diet (25
and 100 g/kg) and day. Responses to insulin and adrenaline
challenges on day 8 were assessed by comparing the area
under the metabolite concentration v. time curve. Data
were analysed by ANOVA.
Results
Growth
There were no significant effects of CLA on average daily
gain (P¼0·77) or feed conversion ratio (P¼0·87) (Table 2).
By design, the group of pigs fed the high-fat diet consumed
significantly less feed per d than the group of pigs fed a
low-fat diet (P¼0·006), ensuring a similar overall energy
intake for the two groups. Feed intake was not significantly
reduced by dietary CLA (P¼0·11).
Effects of dietary fat and conjugated linoleic acid on
plasma metabolite levels
Table 3 shows the average plasma metabolite levels over
the first 7 d of feeding. Plasma NEFA levels in pigs fed
the high-fat diet (Table 3) were significantly higher than
in pigs fed diets lower in fat (P,0·001). Dietary CLA
also increased plasma NEFA such that pigs fed CLA-
supplemented diets had 10·5 and 5·4 % (for low- and
high-fat diets respectively) higher average plasma NEFA
levels than pigs fed with basal diets (P¼0·015) (Table
3). For pigs fed the high-fat diet, the increase in baseline
concentrations of NEFA appeared to be most pronounced
during the first 2 d after the commencement of the present
study, although this was not indicated by any interaction
between dietary CLA and time. The baseline concentration
of plasma triacylglycerol was 9 % higher (P¼0·008)
when CLA supplement was added to the diet and 13 %
greater (P¼0·001) for high- v. low-fat diets (Table 3).
The increase in plasma triacylglycerol due to CLA sup-
plementation was 11 and 7 % for low- and high-fat diets
respectively. There was a linear interaction (P,0·001)
between time and dietary fat content such that the plasma
triacylglycerol concentrations increased with time in pigs
fed the high-fat diet and remained relatively constant in
pigs fed the low-fat diet (Table 3).
Plasma glucose concentrations were not affected by diet-
ary CLA treatment (P¼0·24) or dietary fat (P¼0·39) treat-
ment (Table 3). Similarly, the average plasma insulin
levels were unaffected by dietary CLA (P¼0·30), but
were significantly higher (P¼0·04) in pigs fed the low-
fat diet compared with pigs fed the high-fat diet (Table
3). Plasma urea concentrations were significantly lower
(P¼0·001) in pigs fed the low-fat diets compared with
pigs fed the high-fat diets. The plasma urea concentrations
were not significantly reduced (P¼0·13) in pigs fed dietary
CLA (Table 3).
Adrenaline and insulin challenges
The plasma NEFA and glucose responses to intravenous
Table 2. Effect of dietary fat and conjugated linoleic acid (CLA) on feed and digestible energy (DE)
intake in finisher pigs*
(Mean values for 7 d of feeding)
Fat (g/kg). . . 25 100
Statistical significance of
effect: P
CLA-55 (g/kg)†. . . 0 10 0 10 SED‡ C F C £ F
Rate of gain (kg/d) 0·98 0·84 0·84 0·92 0·13 0·77 0·77 0·27
DE intake (MJ/d) 37·5 35·4 35·4 34·4 1·65 0·11 0·32 0·87
Feed intake (kg/d) 2·54 2·40 2·28 2·17 0·11 0·11 0·006 0·82
Feed:gain 2·64 3·05 2·89 2·39 0·47 0·83 0·60 0·20
C, dietary effect of CLA; F, effect of dietary fat.
* For details of diets and procedures, see Table 1 and p. 626.
† CLA nominally contained 55 g fatty acids as CLA isomers/100 g total fatty acids.
‡ Standard error of the difference for C £ F.
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Table 3. Effect of dietary fat and conjugated linoleic acid (CLA) on plasma constituents in finisher pigs*
Day
Statistical significance of
effects: P§
Fat (g/kg) CLA-55 (g/kg)† 1 2 3 4 5 6 7 SED‡ C F D
NEFA (mmol/l) 25 0 87·1 69·6 71·4 81·5 82·8 76·2 82·9 7·17 0·015 ,0·001 ,0·001
10 93·4 75·8 82·9 88·2 88·9 85·3 101·3
100 0 129·9 109·5 119·1 124·3 118·9 116·8 146·1
10 145·8 120·5 119·6 128·2 124·3 126·6 145·0
Triacylglycerol (mmol/l)k 25 0 20·6 20·2 20·6 21·6 21·8 21·7 21·6 1·75 0·008 ,0·001 ,0·001
10 23·6 21·8 23·1 23·7 25·8 25·1 23·1
100 0 25·1 22·4 22·0 23·9 25·7 29·5 25·5
10 22·6 23·9 24·0 26·0 29·1 32·3 29·2
Glucose (mmol/l) 25 0 5·60 5·30 5·24 5·48 5·61 5·43 5·51 0·177 0·24 0·39 0·21
10 5·42 5·21 5·50 5·34 5·48 5·40 5·52
100 0 5·62 5·54 5·70 5·67 5·55 5·59 5·58
10 5·49 5·47 5·35 5·33 5·46 5·40 5·43
Insulin (mU/ml){ 25 0 13·9 13·4 13·8 15·0 26·7 12·5 15·7 4·02 0·30 0·039 ,0·001
10 16·2 14·9 14·5 15·2 24·9 19·7 20·2
100 0 12·5 12·1 12·8 12·4 11·7 10·7 11·5
10 9·8 13·8 13·3 14·3 16·2 13·2 16·6
Urea (mg/l) 25 0 52·9 54·2 55·2 56·6 55·5 58·5 57·3 3·39 0·13 ,0·001 0·37
10 45·5 42·8 40·5 40·3 40·6 43·2 39·6
100 0 55·1 57·3 55·4 53·9 57·7 58·8 56·6
10 47·3 45·8 47·4 47·9 45·5 47·7 46·9
C, effect of dietary CLA; F, effect of dietary fat; D, effect of day of treatment; NEFA, non-esterified fatty acid.
* Results presented for each day represent the mean value of eight samples taken at 3 h intervals for days 1, 2 and 7 and two samples taken 9 h apart on days 3, 4, 5 and 6. For details of diets and procedures, see
Table 1 and p. 626.
† CLA nominally contained 55 g fatty acids as CLA isomers/100 g total fatty acids.
‡ Standard error of the difference for C £ F £ D.
§ There were no interactions (all P.0·20) except where indicated.
kF £ D interaction, P,0·001 (for details, see p. 627).
{F £ D interaction, P¼0·042 (for details, see p. 627).
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adrenaline or insulin injection are shown in Figs. 1–4. The
metabolic responses to both of these homeostatic signals
were evident within minutes, before quickly returning to
the levels recorded prior to the challenge. The calculated
areas under the metabolite time curves are presented in
Table 4. The intravenous injection of adrenaline stimulated
lipolysis, as shown by an acute increase in plasma NEFA
levels in all pigs. The lipolytic response, as indicated by
area under the curve corrected for baseline, was signifi-
cantly higher (P¼0·018) in pigs fed dietary CLA than in
pigs fed the basal diets (Table 4, Fig. 1(a)). Prior to the
injection of adrenaline, the basal plasma NEFA concen-
trations were significantly (P,0·02) higher in pigs fed
the high-fat diet. After the adrenaline challenge, the
increase in NEFA area under the curve was similar
Fig. 1. Effect of (a), dietary conjugated linoleic acid (CLA) and (b),
fat on plasma non-esterified fatty acids (NEFA) concentration and
responses to adrenaline (3mg/kg) in finisher pigs. (A), No CLA; (B),
CLA; (W), low fat; (†), high fat. Studies were conducted after 8 d of
dietary treatment. For details of diets and procedures, see p. 626.
Since there were no interactions between dietary treatments only
the main effects are shown. The standard error of the difference for
a two-way comparison (dietary treatment £ time) was 13·2mmol/l.
Fig. 2. Effect of (a), dietary conjugated linoleic acid (CLA) and (b),
fat on plasma glucose concentration and responses to adrenaline
(3mg/kg) in finisher pigs. (A), No CLA; (B), CLA; (W), low fat; (†),
high fat. Studies were conducted after 8 d of dietary treatment. For
details of diets and procedures, see p. 626. Since there were no
interactions between dietary treatments only the main effects are
shown. The standard error of the difference for a two-way compari-
son (dietary treatment £ time) was 0·195 mmol/l.
Response to conjugated linoleic acid in pigs 629
(P¼0·78) to that of pigs fed the low-fat diet (Fig. 1(b)).
The intravenous injection of adrenaline caused mild hyper-
glycaemia as shown by an increase in plasma glucose area
under the curve in all dietary treatments (Fig. 2). Plasma
glucose area under the curve after adrenaline injection
was significantly reduced (34–41 %, P¼0·007) in pigs
fed the high-fat diet, but not significantly reduced (17–
26 %, P¼0·12) by dietary CLA (Table 4).
The anti-lipolytic effects of insulin were relatively
modest (Fig. 3). Although there was a significantly greater
(P¼0·036) plasma NEFA area under the curve in response
to insulin over the first 6 min of the challenge in pigs
fed CLA, the area under the curve was not significantly
different over the interval between 0 and 20 min after the
challenge (Fig. 3(a), Table 4). There was no significant
difference in plasma NEFA response (P¼0·98) between
pigs fed different levels of dietary fat (Table 4). On the
Fig. 3. Effect of (a), dietary conjugated linoleic acid (CLA) and (b),
fat on plasma non-esterified fatty acids (NEFA) concentration and
responses to insulin (3mg/kg) in finisher pigs. (A), No CLA; (B),
CLA; (W), low fat; (†), high fat. Studies were conducted after 8 d of
dietary treatment For details of diets and procedures, see p. 626.
Since there were no interactions between dietary treatments only
the main effects are shown. The standard error of the difference for
a two-way comparison (dietary treatment £ time) was 7·58mmol/l.
Fig. 4. Effect of (a), dietary conjugated linoleic acid (CLA) and (b),
fat on plasma glucose concentration and responses to insulin
(3mg/kg) in finisher pigs. (A), No CLA; (B), CLA; (W), low fat; (†),
high fat. Studies were conducted after 8 d of dietary treatment. For
details of diets and procedures, see p. 626. Since there were no
interactions between dietary treatments only the main effects are
shown. The standard error of the difference for a two-way compari-
son (dietary treatment £ time) was 0·178 mmol/l.
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other hand, there was a marked hypoglycaemia in response
to insulin injection (Fig. 4) although there was no effect of
either dietary CLA (P¼0·86) or fat (P¼0·84) on the mag-
nitude of this response (Fig. 4, Table 4).
Discussion
The present study was designed to investigate the inter-
actions between dietary energy source and CLA using
catheterised pigs. While growth performance data are
notoriously unreliable over short periods, it is worth report-
ing that there were no significant effects of CLA on aver-
age daily gain or feed conversion ratio over the 8 d of the
study. In addition, no significant interactions were
observed between CLA and the fat content in the diet for
daily gain, energy intake or feed intake. However, feed
intake tended to be reduced (25 %) by dietary CLA,
although this was not significant (P¼0·11). Other studies
have reported a reduction in feed intake associated with
CLA feeding in mice, in particular in the early stages
(the first 3 weeks) of feeding relatively high levels of
CLA (.10 g/kg) (West et al. 1998). However, the small
suppression in energy intake associated with CLA treat-
ment could not be entirely responsible for the large loss
of body fat content in mice reported by West et al.
(1998) as well as the reduction in fat accretion in pigs
(Ostrowska et al. 1999). Other possible mechanisms
involved include the inhibition of fat deposition from
both preformed fatty acids (lipogenesis) or glucose (de
novo lipogenesis) and/or an increase in fat mobilisation
(lipolysis) in pigs fed dietary CLA. Plasma metabolites
and hormones as well as acute responses to homeostatic
hormones that may indicate changes in these three possible
mechanisms for reduced fat accretion in pigs fed CLA
were therefore investigated in the present study.
Evidence of reduced rate of lipogenesis
Given that pigs are generally fed a high-carbohydrate diet
(Dunshea et al. 1992a), de novo lipogenesis, a process
whereby carbohydrates are converted to triacylglycerol
and stored in the adipose tissue, would represent the
major mechanism for lipid synthesis (Dunshea et al.
1992a). Thus, intuitively, it would be likely that CLA
acts to reduce the rate of de novo lipogenesis. However,
West et al. (1998) reported that the carcass fat content
was decreased in CLA-treated mice regardless of whether
they were fed either a high-carbohydrate or a high-fat
diet. The metabolic results from the present study also
showed no significant interactions between the dietary
CLA and the total fat contents, suggesting that CLA
exerts similar effects in pigs fed either a high-carbohydrate
or a high-fat diet. Hence, in both studies the rates of de
novo synthesis as well as the use of preformed fatty
acids might be reduced by dietary CLA.
In order to study fat transport and metabolism, the key
metabolites and hormones (including triacylglycerol,
NEFA, glucose and insulin) involved in the process of
lipid synthesis were monitored during CLA supplemen-
tation. Fatty acids for lipogenesis can be produced de
novo, principally from glucose in adipose tissue, and the
uptake of glucose into skeletal muscle and adipose tissue
is regulated by insulin (Dunshea et al. 1992b). Therefore,
changes in the rate of lipid deposition may be reflected
in the levels of these plasma metabolites. For example,
pigs fed the high-fat diet had higher plasma triaclyglycerol
concentrations than pigs fed the low-fat diet (Table 3). In
turn, this may have resulted in the higher rate of hydrolysis
of circulating triacylglycerol originating from the high-fat
diet, hence the higher circulating plasma NEFA levels
(Table 3).
Pigs fed the CLA-containing diets had higher plasma
NEFA concentrations than the pigs fed diets without
CLA, regardless of dietary fat content, and this response
appeared to be most pronounced over the first 2 d of
CLA feeding. One of the contributing factors could be a
reduced uptake of the NEFA resulting from hydrolysis of
circulating triacylglycerol catalysed by lipoprotein lipase
at the epithelial cell surface. A reduced uptake of pre-
formed fatty acids is clearly indicated by the higher
levels of circulating triacylglycerol in pigs fed diets con-
taining CLA, despite the tendency towards a reduced
feed intake, and thus dietary fat intake, in these pigs.
Likewise, others have also found a substantial, although
Table 4. Effect of dietary fat and conjugated linoleic acid (CLA) on metabolite responses to insulin and adrenaline
in finisher pigs*
Fat (g/kg). . . 25 100
Statistical significance of
effect: P
CLA-55 (g/kg)†. . . 0 10 0 10 SED‡ C F C £ F
Response to adrenaline
Plasma NEFA (mmol.min/l)§ 88 260 135 243 73 0·018 0·78 0·55
Plasma glucose (mmol.min/l)k 81 67 53 39 12 0·12 0·007 0·98
Response to insulin
Plasma NEFA (mmol.min/l)§ 249 40 243 32 49 0·036 0·98 0·84
Plasma glucose (mmol.min/l)k 281 276 273 280 11 0·86 0·84 0·43
C, effect of dietary CLA; F, effect of dietary fat; NEFA, non-esterified fatty acid.
* For details of diets and procedures, see Table 1 and p. 626.
† CLA nominally contained 55 g fatty acids as CLA isomers/100 g total fatty acids.
‡ Standard error of the difference for C £ F.
§ Sum of response over first 6 min.
kSum of response over first 30 min.
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non-significant increase (24 %) in serum triacylglycerol in
pigs fed CLA (O’Quinn et al. 1998; Stangl et al. 1999).
An increase in plasma triacylglycerol levels in pigs fed
supplemental CLA could be an indication of reduced
activity of lipoprotein lipase. In this context, Park et al.
(1997) found that CLA decreased the heparin-releasable
lipoprotein lipase activity in 3T3-L1 cultured murine adi-
pocytes. Therefore, it is reasonable to hypothesise that a
major effect of CLA on fat accretion is via decreased
lipid synthesis from preformed fatty acids possibly through
reduced lipoprotein lipase activity.
Investigations with lactating cows indicate that the major
effect of CLA on milk fat synthesis is due to a reduced rate
of de novo synthesis (Chouinard et al. 1999; Baumgard
et al. 2001b). CLA was also shown to reduce the mRNA
abundance of lipogenic enzymes including acetyl-CoA car-
boxylase and fatty acid synthetase, two key enzymes in de
novo fatty acid synthesis, in adipose tissue of growing mice
(Tsuboyama-Kasaoka et al. 2000) and in lactating cows
(Baumgard et al. 2001a). However, there was no change
in enzyme activity in weaned pigs fed CLA (Bee, 2000).
To investigate this further, the level of plasma glucose,
which is the primary substrate for de novo lipid synthesis,
was monitored in the present study. The uptake of glucose
is dependent upon insulin, hence the level of this hormone
was also examined. In the present study, dietary CLA had
little effect upon plasma insulin concentrations. Further-
more, no hyperglycaemic responses were evident through-
out the study indicating that glucose production and
utilisation were not markedly influenced by dietary CLA.
However, the insulin:glucose ratio, which is used as a
measure of insulin sensitivity in rodents and human sub-
jects (Legro et al. 1998; Harder et al. 1999) tended to
increase (P¼0·13) with dietary CLA, particularly in pigs
fed the low-fat diet. While this may be indicative of
slight insulin resistance, it was definitely not comparable
with that observed in rodents (DeLany & West, 2000; Tsu-
boyama-Kasaoka et al. 2000).
The rates of glucose clearance, and by inference a com-
ponent of lipogenesis, were further studied by intravenous
infusion of insulin. Insulin, a hormone secreted by the ß
cells of the pancreas, plays a predominant role in the lipo-
genic process. When challenged with insulin, pigs fed the
CLA-supplemented diets appeared to be relatively resistant
to the anti-lipolytic effects of insulin, as indicated by little
change in plasma NEFA concentrations over the first 6 min
after insulin injection. On the other hand, plasma NEFA
concentrations did decrease, albeit only slightly, in
response to insulin injection in the pigs fed diets containing
no CLA. The marginal NEFA responses to insulin are
consistent with very low rates of basal lipolysis in the
growing pig (Dunshea et al. 1992c) and under these con-
ditions, it is very difficult to demonstrate an anti-lipolytic
effect of insulin (Dunshea et al. 1992c; Dunshea & King,
1995). Given the significant, but moderate, difference in
NEFA response between pigs fed different CLA levels, it
is perhaps judicious not to place too much emphasis on
effects of CLA on insulin responses, particularly given
the failure to observe any difference in glucose metabolism
after insulin injection.
Plasma glucose clearance after insulin challenge was not
altered by CLA treatment indicating no change in whole-
body response in glucose uptake. Studies in pre-diabetic
Zucker fatty rats have shown that only at higher concen-
trations of supplemental CLA isomer mix (15 g/kg) is
there any improvement in glucose tolerance and insulin
sensitivity, due to increased uptake of glucose and insulin
levels in skeletal muscle (Houseknecht et al. 1998). House-
knecht et al. (1998) proposed that CLA induced the peroxi-
some proliferator-activated receptor expression, most
probably proliferator-activated receptor-g, a key regulator
of insulin sensitivity. The same group of researchers
(Ryder et al. 2001) later attributed these responses to the
trans-10,cis-12-CLA isomer. It should also be noted that
effects of CLA on insulin sensitivity are more likely to
be observed in animals with metabolic disorders, such as
in the Zucker rat, rather than in normal animals as used
in the present study. In this context, recent studies in lactat-
ing cows showed that abomasal infusion of trans-10,cis-
12-CLA isomer had no effect on the plasma glucose
response to an insulin challenge (Baumgard et al. 2002).
Evidence of increased rate of lipolysis
It is also possible that CLA could exert its effect on lipo-
lysis. The triacylglycerol within the adipocyte can be
hydrolysed by hormone sensitive lipase into NEFA and
glycerol (Pethick & Dunshea, 1993). The rate of fat mobil-
isation may be sufficiently increased to result in the net
reduction in lipid accretion observed in pigs fed dietary
CLA.
Therefore, the small, but significant (P¼0·015) increase
in plasma NEFA in the CLA-fed pigs could be due to
increased fat breakdown and enhanced rate of movement
of fatty acids into b-oxidation for ATP production. In
vitro work with 3T3-L1 adipose cells supported the evi-
dence that CLA potentially enhanced lipolysis and it was
attributed to an increase of the carnitine palmitoyl transfer-
ase activity, both in the adipose tissue of the fed animals
and in the skeletal muscle of fasted mice (Park et al.
1997). If increased fat mobilisation was the source of
increased plasma NEFA in CLA-fed pigs, it would only
be a very small component (about 6 g/d) (Dunshea et al.
1992a,b) of the reduction (86 g/d) in fat accretion in pigs
fed this level of CLA (Ostrowska et al. 1999) based on
the relationship between plasma NEFA concentrations
and NEFA turnover rate (Dunshea et al. 1992c). Hence,
it is unlikely that the major component of the reduced fat
deposition due to CLA supplementation is a result of
increased lipolysis. In this context, there was no change
in plasma NEFA in lactating cows infused with the
trans-10,cis-12-CLA isomer (Baumgard et al. 2002).
An additional indication of an increase in adipose tissue
fat mobilisation during CLA feeding was provided by the
greater increase (+126 %) in plasma NEFA after an intra-
venous adrenaline injection on day 8 of the study (Fig. 3).
Since the plasma NEFA response to adrenaline is an indi-
cator of ß-adrenergic stimulated lipolysis (Sechen et al.
1990; Dunshea et al. 1995; Dunshea & King, 1995),
these results suggest that this response was heightened
during CLA feeding. In dairy cows, infusion of trans-
10,cis-12-CLA, the biologically active isomer that causes
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a marked reduction in milk fat synthesis, had little effect on
NEFA concentrations (basal lipolysis) or circulating leptin
concentrations. However, modest reductions (24–33 %)
in the NEFA response to an adrenaline challenge were
observed in two investigations where cows were treated
with the trans-10,cis-12-CLA isomer compared with the
control and treatment with cis-9,trans-11-CLA (Baumgard
et al. 2002). Hence, there was no indication of increased fat
mobilisation in lactating cows abomasally infused with
trans-10,cis-12-CLA isomer. In the present study, pigs
received a mixture of CLA isomers that was particularly
enriched with both cis-9,trans-11- and the trans-10,cis-
12-CLA isomers, which may in part explain the differ-
ences. In addition, adipose tissue from lactating dairy
cows is much more sensitive (10–100-fold) to catechol-
amines than adipose tissue from growing pigs (Pethick &
Dunshea, 1993). Thus, although the studies used similar
doses of adrenaline they would have been conducted on
the ascending phase and plateau phase of the dose–
response curve in pigs and cows respectively. Therefore,
dietary CLA may have increased sensitivity to adrenaline
in pigs (present study) while decreasing maximal respon-
siveness in cows (Baumgard et al. 2000, 2001a), two scen-
arios that are not mutually exclusive. Regardless, it is still
unlikely that increased fat mobilisation is a major pro-
portion of the reduction in fat deposition during dietary
CLA supplementation in pigs.
After adrenaline injection, the plasma glucose levels in
pigs fed diets high in fat and CLA-fed pigs were lower
than the control pigs, suggesting that there might be
small changes in the ability of the pig liver to respond to
adrenergic stimulation due to dietary fat and CLA. The
importance of these metabolic adaptations to dietary fat
and CLA supplementation is unknown.
Conclusion
In conclusion, results from the present study suggest that
there were no interactions between dietary energy source
and CLA. Dietary CLA-reduced fat accretion in pigs
appears to be largely due to a reduced rate of lipogenesis
from preformed fatty acids, possibly through reduced lipo-
protein lipase activity, and to lesser extent, increased lipo-
lysis. Results from the present study show that plasma
triacylglycerol and NEFA concentrations are increased
during CLA feeding in pigs suggesting alterations in both
the uptake of pre-formed fatty acids and fat breakdown.
However, defining the mechanism(s) of CLA requires a
more definitive understanding of specific dimensions of
lipid metabolism that are responding to CLA treatment.
Further, studies are needed to determine activities of key
lipogenic enzymes involved in the lipid transport and
metabolism in adipose tissue from CLA-treated pigs.
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